| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |